After more than four decades of hepatitis B virus (HBV) vaccine implementation, its safety and
efficacy in preventing HBV infection have been proven and several milestones have been …

Hepatitis C virus (HCV) has a short replication time, high mutation rates and large population
sizes, all of which make it an excellent experimental model for evolution studies, because …

During the first few months of severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2)
evolution in a new host, contrasting hypotheses have been proposed about the way the …

… Federico A. Di Lello: Conception and design of the study, acquisition of data, analysis
and interpretation of data, drafting the article, final approval of the version to be submitted. …

The massive implementation of the vaccine and antiviral agents against hepatitis B virus (
HBV ), targeting the envelope and viral polymerase genes, induces a selection pressure that …

Objective: The aims of this study were to appraise the predictive value of variations in a
single-nucleotide polymorphism (SNP) in the low-density lipoprotein receptor (LDLR) gene for …

Objectives To compare the homologous prime-boost vaccination scheme of Gam-COVID-Vac
(Sputnik V (SpV)) to its heterologous combination with mRNA-1273 (Moderna (Mod)) …

Mycobacterium tuberculosis and Yersinia pestis, the causative agents of tuberculosis and
plague, respectively, are pathogens with serious ongoing impact on global public health 1, 2 …

Previous studies in Argentina have documented a general prevalence of Hepatitis C Virus (HCV)
infection close to 2%. In addition, a high prevalence of HCV has been recently reported …

Background The subtype diversity of the hepatitis C virus (HCV) genotypes is unknown in
Venezuela. Methodology/Principal Findings Partial sequencing of the NS5B region was …